We are live on
!
Find out more
4D Molecular Therapeutics
FDMT
FDMT
153 hedge funds and large institutions have $402M invested in 4D Molecular Therapeutics in 2025 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
310% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $275K
167% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 12
51% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 37
16% more capital invested
Capital invested by funds: $346M → $402M (+$55.9M)
14% more funds holding
Funds holding: 134 → 153 (+19)
8.82% more ownership
Funds ownership: 84.68% → 93.51% (+8.8%)
Holders
153
Holders Change
+19
Holders Change %
+14.18%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
56
Reduced
37
Closed
12
Calls
$1.13M
Puts
$275K
Net Calls
+$853K
Net Calls Change
-$77K
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$29.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$18.1M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$16.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.6M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.1M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$10.7M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.73M |
| 3 |
Two Sigma Advisers
New York
|
-$2.78M |
| 4 |
JP Morgan Chase
New York
|
-$2.37M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.72M |
